No Detail Found!

Centratherum anthelminticum seeds administration improved risk factor markers in metformin treated type 2 diabetic patients

Author(s)
Hina Akram Mudassir Department of Biochemistry, Federal Urdu University of Arts, Science & Technology,Karachi,Pakistan
Rukhsana Rubeen Department of Biochemistry, Dow University of Health Sciences,Karachi,Pakistan
Shamim Akhter Qureshi Department of Biochemistry, University of Karachi,Karachi,Pakistan
Rizwan Ashraf Department of Pharmacology, University College of Medicine and Dentistry, University of Lahore,Lahore,Pakistan
Syed Muhammed Talha Arshad Diabetic Clinic, Sindh Government Hospital,New Karachi,Pakistan
Munazzah Naheed Department of Biochemistry, Federal Urdu University of Arts, Science & Technology,Karachi,Pakistan
Sadia Anwer Department of Biochemistry, Federal Urdu University of Arts, Science & Technology,Karachi,Pakistan
Abstract
This study was designed to assess the effect of Centratherum anthelminticum seeds administration on blood and serum risk factor markers in type 2 diabetic (T2D) patients using metformin. It was a randomized non-blinded, controlled, 3month trial. T2D patients were registered from Sindh Government Hospital New Karachi, Karachi. There were 3 groups, DT (Diabetic Test, n=20), DC (Diabetic Control, n=20) HC (Healthy Control n=20, healthy individuals of similar age were selected). DC (metformin 500mg), DT (capsule of C. anthelminticum seeds powder CAPca + metformin 500mg each) and HC (CAPca 500mg) were given daily. Fasting blood glucose, body weights were monitored weekly while blood samples were collected on first and final day of the trial for biochemistry. Administration of CAPca showed significant decrease in % glycaemia (p<0.0001) and % Hb glycosylation (p<0.05) values. Serum risk factor markers including direct bilirubin & uric acid (p<0.01), creatine kinase & alanine aminotransferase (p<0.0001) and creatinine (p<0.05) were reduced significantly. CAPca administration improved blood and serum markers in healthy volunteers too. These improved blood & serum markers in T2D patients indorsed synergistic effect of CAPca with metformin to manage secondary challenges of T2D.
Publication Details
Page(s) 1869-1873
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 36, Issue: S6, Year: 2023

Request the full text from PASTIC

Keywords
HbA1C, Fasting blood glucose, Inflammatory markers, Centratherum anthelminticum seeds powder, type 2 diabetes (T2D)
0

Citations

0

Downloads

81

Views